Inci

Optimum7 Logistics Partners with R&R Express Logistics to Revolutionize Shipping with Advanced Technology

Retrieved on: 
Wednesday, January 17, 2024
Inci, Multimedia, Partnership, Logistics, LTL, Cargo

MIAMI, Jan. 17, 2024 /PRNewswire-PRWeb/ -- Optimum7 Logistics, a leading provider of innovative logistics and shipping solutions, today announced its strategic partnership with R&R Express Logistics, revolutionizing the industry with advanced technology for efficient and cost-effective shipping operations.

Key Points: 
  • In a groundbreaking move, Optimum7 Logistics partners with R&R Express to introduce a high-tech platform for smarter, faster global shipping solutions.
  • MIAMI, Jan. 17, 2024 /PRNewswire-PRWeb/ -- Optimum7 Logistics, a leading provider of innovative logistics and shipping solutions, today announced its strategic partnership with R&R Express Logistics, revolutionizing the industry with advanced technology for efficient and cost-effective shipping operations.
  • Duran Inci, Founder of Optimum7 Logistics, stated, "Our collaboration with R&R Express Logistics is a game-changer in the logistics industry.
  • The partnership between Optimum7 Logistics and R&R Express Logistics is set to redefine the standards of global shipping and logistics.

HeiQ Viroblock Certified as Cosmetic Grade and Bio-based Renewable

Retrieved on: 
Thursday, July 2, 2020
Cosmetics, Inci, International Nomenclature of Cosmetic Ingredients, Liposome, Ingredients of cosmetics, Branches of biology, Chemistry, Physical sciences

ZURICH, July 2, 2020 /PRNewswire/ --Textile innovator HeiQ's antiviral textile technology, HeiQ Viroblock NPJ03, has been certified as safe and sustainable as all its ingredients are cosmetic grade, bio-based, and recycled.

Key Points: 
  • ZURICH, July 2, 2020 /PRNewswire/ --Textile innovator HeiQ's antiviral textile technology, HeiQ Viroblock NPJ03, has been certified as safe and sustainable as all its ingredients are cosmetic grade, bio-based, and recycled.
  • The HeiQ Viroblock NPJ03 is a formulation that contains a minute amount of recycled silver active ingredient and fatty liposome vesicle components.
  • Furthermore, we are proud that HeiQ Viroblock NPJ03 qualifies as a bio-based renewable product and is 100% made from INCI approved cosmetic ingredients,"says Carlo Centonze, co-founder and Chief Executive Officer of HeiQ Group.
  • HeiQ, Viroblock and HeiQ Viroblock are trademark(s) or registered trademark(s) of HeiQ Materials AG.

HeiQ Viroblock Certified as Cosmetic Grade and Bio-based Renewable

Retrieved on: 
Thursday, July 2, 2020
Cosmetics, Inci, International Nomenclature of Cosmetic Ingredients, Liposome, Ingredients of cosmetics, Branches of biology, Chemistry, Physical sciences

ZURICH, July 2, 2020 /PRNewswire/ --Textile innovator HeiQ's antiviral textile technology, HeiQ Viroblock NPJ03, has been certified as safe and sustainable as all its ingredients are cosmetic grade, bio-based, and recycled.

Key Points: 
  • ZURICH, July 2, 2020 /PRNewswire/ --Textile innovator HeiQ's antiviral textile technology, HeiQ Viroblock NPJ03, has been certified as safe and sustainable as all its ingredients are cosmetic grade, bio-based, and recycled.
  • The HeiQ Viroblock NPJ03 is a formulation that contains a minute amount of recycled silver active ingredient and fatty liposome vesicle components.
  • Furthermore, we are proud that HeiQ Viroblock NPJ03 qualifies as a bio-based renewable product and is 100% made from INCI approved cosmetic ingredients,"says Carlo Centonze, co-founder and Chief Executive Officer of HeiQ Group.
  • HeiQ, Viroblock and HeiQ Viroblock are trademark(s) or registered trademark(s) of HeiQ Materials AG.

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Notice of Allowance from USPTO for Trademark of Atopidine™

Retrieved on: 
Thursday, April 9, 2020
Cytokines, Medical specialties, Branches of biology, Medicine, Inci, Cytokine, Tumor necrosis factor alpha, CXCL5, Inflammatory cytokine, International Nomenclature of Cosmetic Ingredients

Kannalife chose Atopidine as the trademark for Limonenyldihydroxybenzyl Ethoxycarbonyl Azetidine ("LEA"), the International Nomenclature of Cosmetic Ingredient (INCI) assigned name for its patented monotherapeutic compound KLS-13022.

Key Points: 
  • Kannalife chose Atopidine as the trademark for Limonenyldihydroxybenzyl Ethoxycarbonyl Azetidine ("LEA"), the International Nomenclature of Cosmetic Ingredient (INCI) assigned name for its patented monotherapeutic compound KLS-13022.
  • "Kannalife is a leader of research and development in the field of cannabinoid therapeutics," said Medical Marijuana, Inc. CEO Dr. Stuart Titus.
  • In pre-clinical testing, Atopidine was shown to decrease inflammatory cytokine (TNF, Il-1, CXCL5 and IL-8) levels at concentrations 50 times less than toxic levels.
  • Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

Kannalife, Inc. Receives Notice of Allowance from USPTO for Trademark of Atopidine™

Retrieved on: 
Wednesday, April 1, 2020
Cytokines, Medical specialties, Branches of biology, Medicine, Photoaging, Tumor necrosis factor alpha, Inflammatory cytokine, CXCL5, Cytokine, Inci, IL-6

The Company chose Atopidine as the trademark for Limonenyldihydroxybenzyl Ethoxycarbonyl Azetidine (LEA), the International Nomenclature of Cosmetic Ingredient (INCI) assigned name for the Companys patented monotherapeutic compound KLS-13022.

Key Points: 
  • The Company chose Atopidine as the trademark for Limonenyldihydroxybenzyl Ethoxycarbonyl Azetidine (LEA), the International Nomenclature of Cosmetic Ingredient (INCI) assigned name for the Companys patented monotherapeutic compound KLS-13022.
  • In pre-clinical testing, Atopidine was shown to decrease inflammatory cytokine (TNF, Il-1, CXCL5 and IL-8) levels at concentrations 50 times less than toxic levels.
  • Atopidine was effective in an in vitro photoaging experiment with anti-inflammatory action based on IL-6 inhibition against UVA irradiation in cultured human dermal fibroblasts cells.
  • The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Secures New INCI Name for Its Prospective Anti-Inflammatory and Antioxidant Ingredient Atopidine™

Retrieved on: 
Wednesday, January 8, 2020
Cannabis, Drugs, Inci, Cannabidiol, Medical Marijuana, Inc., International Nomenclature of Cosmetic Ingredients, KannaLife

TheInternational Cosmetic Ingredient Nomenclature Committee assigned the INCI name "Limonenyldihydroxybenzyl Ethoxycarbonyl Azetidine" ("LEA") to Atopidine, one of Kannalife's leading novel cannabidiol (CBD)-like molecules.

Key Points: 
  • TheInternational Cosmetic Ingredient Nomenclature Committee assigned the INCI name "Limonenyldihydroxybenzyl Ethoxycarbonyl Azetidine" ("LEA") to Atopidine, one of Kannalife's leading novel cannabidiol (CBD)-like molecules.
  • "We believe the INCI name assignment is one of the most important steps forward in the commercialization of Atopidine," said Dean Petkanas, CEO of Kannalife.
  • Medical Marijuana, Inc.'s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com .
  • Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

Kannalife Secures New INCI Name for its Prospective Anti-Inflammatory and Antioxidant Ingredient Atopidine™

Retrieved on: 
Tuesday, January 7, 2020
Inci, KannaLife, International Nomenclature of Cosmetic Ingredients, Doylestown, Natural sciences

The International Cosmetic Ingredient Nomenclature Committee assigned the INCI name "Limonenyldihydroxybenzyl Ethoxycarbonyl Azetidine (LEA) to Atopidine, one of Kannalifes leading novel CBD-like molecules.

Key Points: 
  • The International Cosmetic Ingredient Nomenclature Committee assigned the INCI name "Limonenyldihydroxybenzyl Ethoxycarbonyl Azetidine (LEA) to Atopidine, one of Kannalifes leading novel CBD-like molecules.
  • Current pre-clinical research into Atopidine has shown this molecule to exhibit strong anti-inflammatory and antioxidant potential applicability in addressing a number of consumer skin and personal care needs, said Dean Petkanas, CEO of Kannalife.
  • "We believe the INCI name assignment is one of the most important steps forward in commercialization of Atopidine.
  • Kannalife conducts its research and development efforts at the Pennsylvania Biotechnology Center of Bucks County in Doylestown, PA.
    For more information about Kannalife, Inc., visit www.kannalife.com and visit the Companys Twitter page at @Kannalife.

Solabia Group Announces its Acquisition of Algatech, a Global Leader in the Microalgae Industry

Retrieved on: 
Wednesday, May 22, 2019
Health, Biotechnology, Fitness & Nutrition, Manufacturing, Chemicals, Plastics, Natural Resources, Agriculture, Professional services, Finance, Aquatic ecology, Biological oceanography, Microalgae, Planktology, Inci, Food, Ingredients of cosmetics

Solabia Group (Solabia) today announces that it has acquired Algatech Ltd. (Algatech or the Company), a global innovative leader in the development, cultivation and commercialisation of ingredients delivered from microalgae and used by leading food supplement, food and cosmetic brands worldwide.

Key Points: 
  • Solabia Group (Solabia) today announces that it has acquired Algatech Ltd. (Algatech or the Company), a global innovative leader in the development, cultivation and commercialisation of ingredients delivered from microalgae and used by leading food supplement, food and cosmetic brands worldwide.
  • Commenting on the acquisition, Hagai Stadler, Chief Executive Officer of Algatech, said:
    We are excited to announce Algatechs acquisition by Solabia.
  • Solabia is a major player in the global cosmetic ingredients market with presence in the Americas, Europe, Asia and Africa.
  • The companys products are principally used in the agro-food industry to detect bacteria, such as salmonella, legionella or listeria.